Financials

News Ideas Technicals Forecast

BCRX fundamentals

Overview Statements Statistics Dividends Earnings Revenue

The current financial position of BioCryst Pharmaceuticals, Inc.

Total assets of BCRX for Q4 23 is 516.96 M USD, 1.14% less than the previous Q3 23. And total liabilities increased by 4.13% in Q4 23 to 972.49 M USD.

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

‪0.00‬

Total assets

Total liabilities

Income statement Balance sheet Cash flow

Currency: USD

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—